Duality Advisers, LP Alnylam Pharmaceuticals, Inc. Transaction History

Duality Advisers, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$146.51 - $198.2 $866,606 - $1.17 Million	-5,915 Reduced 34.57%	11,197 $1.67 Million
Q4 2023 Feb 01, 2024	BUY	$151.41 - $196.57 $1.16 Million - $1.51 Million	7,682 Added 81.46%	17,112 $3.28 Million
Q3 2023 Nov 02, 2023	BUY	$170.77 - $211.65 $972,876 - $1.21 Million	5,697 Added 152.61%	9,430 $1.67 Million
Q2 2023 Jul 31, 2023	BUY	$185.01 - $212.05 $311,186 - $356,668	1,682 Added 82.01%	3,733 $709,000
Q1 2023 Jun 27, 2023	BUY	$182.66 - $235.53 $374,635 - $483,072	2,051 New	2,051 $410,000
Q3 2022 Nov 03, 2022	BUY	$138.54 - $232.0 $1.84 Million - $3.08 Million	13,274 Added 363.47%	16,926 $3.39 Million
Q2 2022 Aug 08, 2022	SELL	$120.42 - $169.29 $219,043 - $307,938	-1,819 Reduced 33.25%	3,652 $533,000
Q1 2022 May 09, 2022	SELL	$127.18 - $173.91 $852,360 - $1.17 Million	-6,702 Reduced 55.06%	5,471 $893,000
Q4 2021 Feb 02, 2022	SELL	$159.56 - $209.29 $738,922 - $969,221	-4,631 Reduced 27.56%	12,173 $2.06 Million
Q3 2021 Nov 08, 2021	BUY	$169.75 - $207.73 $2.85 Million - $3.49 Million	16,804 New	16,804 $3.17 Million
Q2 2021 Aug 09, 2021	SELL	$128.63 - $176.89 $1.55 Million - $2.13 Million	-12,039 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$126.83 - $175.69 $631,740 - $875,111	-4,981 Reduced 29.27%	12,039 $1.7 Million
Q4 2020 Feb 09, 2021	BUY	$122.97 - $147.0 $2.09 Million - $2.5 Million	17,020 New	17,020 $2.21 Million

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $28.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.